𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin

✍ Scribed by Rosanna Supino; Monica Binaschi; Giovanni Capranico; Romolo A. Gambetta; Elena Sala; Franco Zunino; Ennio Prosperi

Publisher
John Wiley and Sons
Year
1993
Tongue
French
Weight
920 KB
Volume
54
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A doxorubicin‐resistant variant of the human small‐cell lung‐cancer cell line N592 was selected by in vitro continuous exposure to increasing drug concentrations. The aim of this study was to examine the cross‐resistance pattern, cellular pharmacokinetics of doxorubicin and expression of molecular factors of resistance. The sub‐line N592/DX exhibited a multidrug‐resistance phenotype, which was somewhat atypical, since it included cisplatin. Development of doxorubicin resistance could not be attributed to differential doxorubicin uptake or retention. Verapamil partially reverted doxorubicin resistance without affecting cellular pharmacokinetics. These findings are consistent with undetectable levels of __mdr‐__1 ‐gene expression in these cells. A molecular analysis of other putative mechanisms of multidrug resistance indicated no alterations in GSH levels or GSH‐related enzymes, but a marginal reduction of topoisomerase II α expression in the resistant sub‐line. This reduction, which was associated with an increase in topoisomerase I, does not explain the high degree of resistance. This study supports the view that alternative, unidentified mechanisms, which may be of clinical relevance, must be involved in the development of multidrug resistance of small‐cell lung cancer.

📜 SIMILAR VOLUMES

Doxorubicin induces expression of multid
Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway
✍ Chie Shinoda; Muneharu Maruyama; Takashi Fujishita; Junichi Dohkan; Hirofumi Oda 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 646 KB

Multidrug resistance (MDR) is a major impediment to successful chemotherapy for lung cancer. Overexpression of multidrug resistance-associated protein 1 (MRP1) appears to be involved in MDR development in lung cancer cells. A number of chemotherapeutic agents including doxorubicin (DOX) were reporte

MRP gene overexpression in a human doxor
MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: Alterations in cellular pharmacokinetics and in pattern of cross-resistance
✍ Monica Binaschi; Rosanna Supino; Romolo A. Gambetta; Giuseppe Giaccone; Ennio Pr 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 697 KB

## Abstract The development of non‐P‐glycoprotein‐mediated multidrug resistance is a frequent event among lung‐cancer cell lines. In an attempt to understand the underlying mechanisms of this phenotype, we have selected a multi‐drug‐resistant subline (POGB/DX) __in vitro__ for doxorubicin resistanc

Expression of MRP and mdr1 in human gast
Expression of MRP and mdr1 in human gastrointestinal cancer cell lines: A correlation with resistance against doxorubicin
✍ Murase, Masaharu; Kodera, Yasuhiro; Kondo, Ken; Sekiguchi, Hiroyuki; Fujiwara, M 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 596 KB

## ~ ~~~~ The mRNA expression of mdrl and MRP, each of which codes for a transport protein belonging to ATP-binding cassette superfamily and are reported to be responsible for multidrug resistance phenotype, were semiquantified by RT-PCR in a panel of gastrointestinal cancer cell lines. Although t

p21Waf1/cip1 acts in synergy with bcl-2
p21Waf1/cip1 acts in synergy with bcl-2 to confer multidrug resistance in a camptothecin-selected human lung-cancer cell line
✍ Yongke Zhang; Naoya Fujita; Takashi Tsuruo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 217 KB 👁 1 views

The realization that chemotherapeutic agents induce apoptosis raises the concern that tumors resistant to chemotherapy are unable to initiate the apoptotic program. In the present study, we examined the apoptosis-resistance mechanism of a multidrug-resistant cell line, A549/CPT, which was establishe

Mechanism of resistance to cisplatin in
Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: Possible role of p53
✍ Faina Vikhanskaya; Luana Clerico; Monica Valenti; Maria S. Stanzione; Massimo Br 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 99 KB 👁 2 views

A possible novel mechanism of cross-resistance to cisplatin (CDDP) in the doxorubicin-resistant ovarian-cancer cell line A2780-DX3, which displays atypical multidrug resistance, is presented. A2780-DX3 is found to be more resistant than the parental line A2780 in terms of CDDP-induced cytotoxicity a